Cutler Group LLC / CA - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,160,000
+0.2%
7,486
-59.5%
0.06%
+3.6%
Q4 2020$1,158,000
-4.8%
18,502
-2.1%
0.06%
-26.7%
Q3 2020$1,216,000
+14.7%
18,902
+13.3%
0.08%
+7.1%
Q2 2020$1,060,000
-12.3%
16,676
-29.7%
0.07%
+12.9%
Q1 2020$1,208,000
+133.2%
23,725
-4.7%
0.06%
+100.0%
Q4 2019$518,000
-34.4%
24,901
-41.7%
0.03%
-56.9%
Q3 2019$790,000
+259.1%
42,700
+151.2%
0.07%
+260.0%
Q2 2019$220,000
-31.7%
17,000
+134.4%
0.02%
-39.4%
Q1 2019$322,000
-42.5%
7,252
-78.1%
0.03%
-37.7%
Q4 2018$560,000
-51.1%
33,164
-0.7%
0.05%
-32.9%
Q3 2018$1,145,000
+16.5%
33,400
+39.1%
0.08%
+1.3%
Q2 2018$983,000
+10.7%
24,003
-30.2%
0.08%
+1.3%
Q1 2018$888,000
-28.4%
34,403
-66.7%
0.08%
+51.0%
Q4 2017$1,240,000
+5.9%
103,300
-9.0%
0.05%
+15.9%
Q3 2017$1,171,000
-30.7%
113,511
-14.4%
0.04%
-29.0%
Q2 2017$1,690,000
-48.6%
132,674
-40.1%
0.06%
-54.7%
Q1 2017$3,291,000
+7.7%
221,547
-43.6%
0.14%
+24.5%
Q4 2016$3,057,000
-53.6%
393,130
-10.7%
0.11%
-62.8%
Q3 2016$6,592,000
+29.8%
439,990
+27.9%
0.30%
+14.3%
Q2 2016$5,077,000
+16.2%
344,072
-11.6%
0.26%
-10.1%
Q1 2016$4,370,000
+39.7%
389,081
+64.2%
0.29%
+64.6%
Q4 2015$3,129,000236,9800.18%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders